Busting your boomer parents' myths about CBD

Busting your boomer parents' myths about CBD

By Trisha Malhotra

Opinions on cannabidiol (CBD) are the prime example of the phrase ‘two sides of the same coin.’ It is extraordinary that a single compound can garner such an intense polarised debate. Pedaled as either a marketing myth or sold as a multipurpose elixir, just the mention of CBD seems to garner extreme responses depending on who you’re talking to. But what are the facts about CBD? Here’s what we know.

Myth - CBD is derived from cannabis so it’ll get you high.

Fact: CBD is derived from Cannabis sativa, but it will not get you high. The high feeling can be attributed to THC — Tetrahydrocannabinol. This is another compound found in Cannabis. Different strains of the plant contain varying amounts of CBD and THC. Pure CBD extract will contain no THC, and therefore won't cause loopy feelings. 

Myth - There is inconclusive data on CBD’s clinical efficacy. 

Fact: We can no longer claim that evidence for CBD is not concrete enough when it comes to treating conditions like seizures, generalized anxiety, and inflammation. In fact, last year, the Food and Drug Administration authorized a drug containing CBD called Epidiolex for the treatment of seizure-related disorders. The clinical trials of Epidiolex were compelling enough for the FDA to approve it. Multiple credible double-blind randomized studies have been done all over the world regarding CBD’s efficacy. Here are three examples:

  • A 2018 United Kingdom study showed encouraging results for using CBD as a means of treating ulcerative colitis.
  • A 2017 study conducted in Brazil noted how a group of people who consumed CBD had less anxiety when public speaking than the control, who took a placebo. 
  • A 2014 study out of Italy indicated that CBD can inhibit the growth of cancerous cells for those with colon cancer.

Myth - CBD is a marketing gimmick. 

Fact: Depends on the marketing. If CBD is marketed as an anti-inflammatory, for seizure-related conditions, or as a sleeping aid, it most likely isn’t a marketing gimmick. If CBD is marketed as an all-in-one miracle worker, its effects are probably being overblown by false advertising. There are legitimate applications for the compound, but it is the due diligence of consumers to educate themselves on the facts about CBD.  

Myth - CBD is a Schedule 1 narcotic meaning it has “no medical value.”

Fact: The status of CBD as a Schedule 1 narcotic in the United States is accurate. Any drug falling under this status is claimed to possess no medical value. However, experts, including the FDA themselves, seem to be questioning it. A key facet to consider here is that this status was assigned to CBD in 1970. As indicated by the studies above, CBD has incredible medical potential which has only been discovered in recent years. While it remains part of Schedule 1, it is difficult to carry out clinical trials using it in the United States. However, the phrase ‘no medical value’ does not do CBD justice. 

Myth - CBD is probably not safe to use. 

Fact: A detailed report from the World Health Organization declared that naturally occurring CBD is both safe and well-tolerated in humans, provided it is consumed in appropriate doses as per weight/age/sex. CBD products have been used as a treatment option for anxiety, schizophrenia, seizures, depression, acne, and even heart disease. However, not all CBD products are created equal. Sourcing, manufacturing, and quality control can differ greatly. It's vital to find reputable brands with transparency regarding their manufacturing process and sourcing. 

References

https://www.healthline.com/health/myths-about-cbd#Doing-your-due-diligence-when-it-comes-to-research-is-key

https://lifestyle.livemint.com/health/wellness/debunking-myths-about-cbd-111626107736729.html

 

Back to blog